Physician profile
Logan A Reimer
NPI 1134653876
$3,812.06
in general payments reported to CMS, 2019-2025
20 companies · $181 in 2025
The $181 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.55 · 2020: $99.00 · 2021: $445 · 2022: $1,587 · 2023: $1,058 · 2024: $351 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,490 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,489.85 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,136.04 | 2019-2025 | Watchman Access System, Crossboss, Rotablator Rotational Atherectomy System Console Kit |
| Abbott Laboratories | $551.32 | 2021-2023 | Ensite, Mitraclip |
| Medtronic, INC. | $378.28 | 2021-2022 | |
| Amgen INC. | $257.90 | 2022-2024 | Repatha |
| Abiomed | $239.01 | 2021-2023 | Impella |
| Astrazeneca Pharmaceuticals LP | $212.88 | 2020-2023 | Brilinta |
| Novartis Pharmaceuticals Corporation | $164.00 | 2023-2024 | |
| Astellas Pharma US INC | $153.98 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $110.14 | 2023-2024 | Lifevest |
| Pfizer INC. | $108.68 | 2024-2025 | |
| Edwards Lifesciences Corporation | $107.90 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Biosense Webster, INC. | $85.49 | 2022-2023 | Carto 3 |
| Shockwave Medical, INC | $85.41 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| United Therapeutics Corporation | $77.89 | 2021 | |
| Janssen Pharmaceuticals, INC | $52.98 | 2023 | Xarelto |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $22.73 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $19.54 | 2024 | Camzyos |
| Kiniksa Pharmaceuticals, LTD. | $17.33 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.90 | 2022 | |
| Merck Sharp & Dohme LLC | $13.66 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Logan Reimer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.